Kura Oncology
KURA
Kura Oncology (KURA) news
Recent news
Kura Oncology 2Q loss/share 77c, est. loss/share 86c
Kura Oncology, Inc. (Nasdaq: KURA) reported a net loss per share of $0.75 for the second quarter of 2025, which was slightly better than the estimated loss per share of $0.86. The company’s net loss for the quarter totaled $66.1 million, compared to net loss of $50.8 million in the same period in…
AInvest Wire · Aug 12, 2026Kura Oncology 2Q R&D expenses $61.9M, est. $67.9M
AInvest Wire · Aug 12, 2026Kura Oncology 2Q net loss $68.3M, est. loss $77.4M
AInvest Wire · Aug 12, 2026Kura Oncology reports inducement grants under Nasdaq listing rule 5635(c)(4)
AInvest Wire · Jun 5, 2026Kura Oncology 1Q loss/share 83c, est. loss/share 84c
AInvest Wire · May 12, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.